Perioperative management of antiphospholipid antibody-positive patients

Current Rheumatology Reports

Volumn 16, Issue 7, 2014, Pages

  Saunders, Katherine H ^a   Erkan, Doruk ^b   Lockshin, Michael D ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Perioperative management; Surgery

Indexed keywords

CORTICOSTEROID; HEPARIN; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PHYTOMENADIONE; VITAMIN K GROUP; WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; COMPRESSION STOCKING; CONTINUOUS INFUSION; DISEASE CLASSIFICATION; DRUG MEGADOSE; EMERGENCY SURGERY; EPIDURAL CATHETER; EPIDURAL HEMATOMA; HIGH RISK PATIENT; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; INTERNATIONAL NORMALIZED RATIO; KIDNEY TRANSPLANTATION; NEUROSURGERY; OPERATIVE BLOOD LOSS; PATIENT ASSESSMENT; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE ANALGESIA; POSTOPERATIVE THROMBOSIS; PREOPERATIVE EDUCATION; PREOPERATIVE EVALUATION; REGIONAL ANESTHESIA; RISK REDUCTION; SPINAL HEMATOMA; SURGICAL PATIENT; SURGICAL RISK; THROMBOSIS PREVENTION; TREATMENT PLANNING; VEIN THROMBOSIS; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM; COMPLICATION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROCEDURES; RISK ASSESSMENT; THROMBOSIS;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; RISK ASSESSMENT; THROMBOSIS;

EID: 84901303455     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-014-0426-7     Document Type: Article

References (58)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
2. •• Saunders KH, Erkan D. Perioperativemanagement of antiphospholipid antibody positive patients during non-cardiac surgeries. In: Mandell BF, editor. Perioperative management of the patient with rheumatic disease. 1st ed. New York: Springer; 2012. p. 91-107. This book chapter is a review of the perioperative management of aPL-positive patients undergoing noncardiac surgery. It provides a detailed analysis of the literature and offers expert recommendations. It also includes information on the role of aspirin, hydroxychloroquine, and statins during the perioperative period.
3. Asherson RA, Cervera R, de Groot PG, for the Catastrophic Antiphospholipid Syndrome Registry Project Group, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530-4. (Pubitemid 36890145)
4. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun. 2000;15:145-51.
5. Vila P, Hernández MC, López-Fernández MF, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost. 1994;72:209-13. (Pubitemid 24251281)
6. Erkan D, Lockshin M. New approaches for managing antiphospholipid syndrome. Nat Clin Pract Rheumatol. 2009;5: 160-70.
7. Fischetti F, Durigutto P, Pellis V, et al. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood. 2005;106:2340-6. (Pubitemid 41510805)
8. Kaul M, Erkan D, Sammaritano L, Lockshin MD. Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2007;66:927-30. (Pubitemid 46999795)
9. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford). 2002;41:924-9.
10. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore). 2001;80:355-76.
11. •• Bartholomew JR. Perioperative management of anticoagulation in the patient with the antiphospholipid syndrome in cardiac surgery and cardiac interventions. In: Mandell BF, editor. Perioperative management of the patient with rheumatic disease. 1st ed. New York: Springer; 2012. p. 109-27. This book chapter is a review of the peioperative management of patients with APS undergoing cardiac procedures.
12. Avcin T, Toplak N. Antiphospholipid antibodies in response to infection. Curr Rheumatol Rep. 2007;9:212-8. (Pubitemid 46954779)
13. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827-32. (Pubitemid 36237580)
14. Pengo V, Biasiolo A, Gresele P, for the Participating Centres of Italian Federation of Thrombosis Centres (FCSA), et al. Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost. 2007;5:925-30. (Pubitemid 46691720)
15. Pengo V, Tripodi A, Reber G, for the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis, et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost. 2009;7:1737-40.
16. Trappe R, Loew A, Thuss-Patience P, Dörken B, Riess H. Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab - monitoring of antiphospholipid and anti-GP antibodies: a case report. Ann Hematol. 2006;85:134-5. (Pubitemid 43085311)
17. Galli M, Finazzi G, Barbui T. Thrombocytopenia in the antiphospholipid syndrome. Br J Haematol. 1996;93:1-5. (Pubitemid 26130709)
18. Erkan D, Bateman H, Lockshin MD. Lupus anticoagulanthy-poprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature. Lupus. 1999;8:560-4. (Pubitemid 29452571)
19. Erkan D, Leibowitz E, Berman J, Lockshin MD. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol. 2002;29:843-9. (Pubitemid 34303882)
20. Vinet E, Rich E, Senécal JL. Thromboembolism complicating the treatment of lupus anticoagulant hypoprothrombinemia syndrome. J Rheumatol. 2006;33:2088-90. (Pubitemid 44571889)
21. Simel D, St. Claire EW, Adams J, Greenberg C. Correction of hypothrombinemia by immunosuppressive treatment of lupus anticoagulant- hypoprothrombinemia syndrome. Am J Med. 1987;83:563-6.
22. Asherson RA, Chan JK, Harris EN, Gharavi AE, Hughes GR. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis. 1985;44:823-5. (Pubitemid 16222235)
23. Palareti G, Legnani C, Guazzaloca G, et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants - a prospective study. Thromb Haemost. 1994;72:222-6. (Pubitemid 24251284)
24. Yamamoto T, Ito M, Nagata S, et al. Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy. J Rheumatol. 2000;27:2035-7. (Pubitemid 30670499)
25. Chouhan VD, Comerota AJ, Sun L, Harada R, Gaughan JP, Rao AK. Inhibition of tissue factor pathway during intermittent pneumatic compression: a possible mechanismfor antithrombotic effect. Arterioscler Thromb Vasc Biol. 1999;19:2812-7. (Pubitemid 29536063)
26. Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev. 2008;4, CD005258.
27. Sevitt S. Pathology and pathogenesis of deep vein thrombosis. In: Bergan J, Yao J, editors. Venous problems. Chicago: Year Book; 1976. p. 257-69.
28. Kraai EP, Lopes RD, Alexander JH, Garcia D. Perioperative management of anticoagulation: guidelines translated for the clinician. J Thromb Thrombolysis. 2009;28:16-22.
29. Geerts WH, Bergqvist D, Pineo GF, for the American College of Chest Physicians, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:381S-453.
30. Douketis JD, Berger PB, Dunn AS, for the American College of Chest Physicians, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:299S-339.
31. Faltas B, Kouides PA. Update on perioperative bridging in patients on chronic oral anticoagulation. Expert Rev Cardiovasc Ther. 2009;7:1533-9.
32. Price EA, Jin J, Nguyen HM, Krishnan G, Bowen R, Zehnder JL. Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin. Ann Pharmacother. 2013;47(2):151-8.
33. Muhsin SA, Khianey R, Erkan D. Comment: discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin. Ann Pharmacother. 2013;47(9):1239-40.
34. Horlocker TT, Heit JA. Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg. 1997;85:874-5.
35. Horlocker TT,Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition). Reg Anesth Pain Med. 2010;35:64-101.
36. Silverberg M, Erkan D, Lockshin MD. Hemorrhage in the antiphospholipid syndrome: the challenge of anticoagulation. Arthritis Rheum. 2002;46:S52.
37. Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014.
38. Bobba RS, Crowther MA. Perioperative management of the patient with immune thrombocytopenic purpura de novo and the thrombocytopenia of antiphospholipid antibody syndrome. In: Mandell BF, editor. Perioperative management of the patient with rheumatic disease. 1st ed. New York: Springer; 2012. p. 129-35.
39. Tenedios F, Erkan D, Vega J, Ramon G, Kozora E, Lockshin MD. Rituximab in Antiphospholipid Syndrome (RITAPS) - a pilot openlabel phase II prospective trial for non-criteria manifestations of antiphospholipid antibodies. Arthritis Rheum. 2013;65(2):464-71.
40. Raflores MB, Kaplan RB, Spero JA. Pre-operative management of a patient with hypoprothrombinemialupus anticoagulant syndrome. Thromb Haemost. 2007;98:248-50. (Pubitemid 47074203)
41. Drazin D, Westley Phillips H, Shirzadi A, Drazin N, Schievink W. Neurosurgical management for complicated catastrophic antiphospholipid syndrome. J Clin Neurosci. 2014;21(4):680-3.
42. Erkan D. Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Autoimmun Rev. 2006;6:98-103. (Pubitemid 44816525)
43. Deane KD, West SG. Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum. 2005;35:154-65. (Pubitemid 41713955)
44. Vigué B. Bench-to-bedside review: optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice. Crit Care. 2009;13:209.
45. Cerrato D, Ariano C, Fiacchino F. Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg. 1978;49:378-81. (Pubitemid 9013317)
46. Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med. 2000;160:2327-32.
47. Cheng JS, Arnold PM, Anderson PA, Fischer D, Dettori JR. Anticoagulation risk in spine surgery. Spine (Phila Pa 1976). 2010;35:S117-24.
48. Stone JH, Amend WJ, Criswell LA. Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am J Kidney Dis. 1999;34:1040-7.
49. McIntyre JA, Wagenknecht DR. Antiphospholipid antibodies. Risk assessments for solid organ, bone marrow, and tissue transplantation. Rheum Dis Clin N Am. 2001;27:611-31. (Pubitemid 32781419)
50. Raklyar I, DeMarco J, Wu J, Light J, Timbil S, Weinstein A. Anticardiolipin antibody positivity correlates with poor graft survival in renal transplantation for systemic lupus erythematosus [abstract]. Arthritis Rheum. 2005;52:S384-5.
51. Canaud G, Bienaimé F, Noël LH, et al. Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies. Am J Transplant. 2010;10(9):2051-60.
52. Wagenknecht DR, Becker DG, LeFor WM, McIntyre JA. Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation. 1999;68:241-6. (Pubitemid 29360284)
53. Forman JP, Lin J, Pascual M, Denton MD, Tolkoff-Rubin N. Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant. 2004;4:1786-91. (Pubitemid 39434438)
54. Furmańczyk-Zawiska A, Ba̧czkowska T, Sadowska A, Szmidt J, Chmura A, Durlik M. Antiphospholipid antibodies in renal allograft recipients. Transplant Proc. 2013;45(4):1655-60.
55. Vaidya S, Sellers R, Kimball P, et al. Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study. Transplantation. 2000;69:1348-52. (Pubitemid 30238722)
56. Domingues V, Dadhania D, Hartona C, Pastore R, Erkan D. Hospital for Special Surgery - Cornell Protocol for Antiphospholipid Antibody Positive Patients Undergoing Renal Transplantation. 14th International Congress on aPL Abstract Book 2013;316:70.
57. Cherian J, Gertner E. Recurrent pulmonary embolism despite inferior vena cava filter placement in patients with the antiphospholipid syndrome. J Clin Rheumatol. 2005;11:56-8. (Pubitemid 40223882)
58. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998;338:409-15. (Pubitemid 28135667)